Kowa Pharmaceuticals America, Inc. announces INTREPID trial results in The Lancet HIV showing superior LDL cholesterol reduction with Livalo (pitavastatin) compared with pravastatin in adults with HIV and dyslipidemia. Kowa Pharmaceuticals America, Inc. today announced publication of results of the INTREPID trial (HIV-infected patients and treatment with pitavastatin vs. pravastatin for dyslipidemia) in The Lancet HIV. Results of the…